MELINDA GRIFFITH
Profile
First Name
: MELINDA
Middle Name
:
Last Name
: GRIFFITH
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
BROOK BYERS, BROOK H. BYERS, GWEN R. CARSCADDEN, FRED COHEN, SUSAN DANIELS, PATRICK ENRIGHT, PATRICK G. ENRIGHT, WILLIAM ERICSON, MICHAEL GOLDBERG, ANDREW L. GUGGENHIME, JEFF HEER, TIM HENN, HONGJIE HU, DEBORAH L. KILPATRICK, LOUIS G. LANGE, DAVID LEVISON, DAVID L. LEVISON, KHUSHRO F. MEHTA, MARK MONANE, ARTHUR M. PAPPAS, AMY PAYE, STEVEN ROSENBERG, DOUGLAS T. ROSS, AJIT SINGH, RISA STACK, JAMES R. TOBIN, RAFAEL TORRES, MARK WEEKS, ROBERT F. WERNER, DUANE WILLIAMS, MARK .R. WILLIG, JIM WINGROVE
DIRECTOR
RONALD ANDREWS, RONALD A ANDREWS, WILLIAM ANNETT, ANDREW ARNO, ANDY ARNO, DON BAILEY, JENNIFER LEVIN CARTER, KAREN B. CHAPMAN, ANDREA JAMES, ALFRED KINGSLEY, ALFRED D KINGSLEY, ALFRED D. KINGSLEY, ANDREW LAST, ANDREW J LAST, MITCH LEVINE, MITCHELL LEVINE, JAMES LIU, KRISTINE C. MECHEM, ADITYA MOHANTY, ALBERT PARKER, ROBERT W. PEABODY, CAVAN REDMOND, JOSHUA RIGGS, DOUGLAS T ROSS, LOUIS SILVERMAN, RUSSELL SKIBSTED, PADMAVATHI SUNDAR, JOSEPH WAGNER, MICHAEL WEST
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2021-04-15
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2021-02-24
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2020-01-31
D
BIOTECHNOLOGY
SERVICES-MEDICAL LABORATORIES [8071]
DECLINE TO DISCLOSE
Equity
2014-07-19
